| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dbbd83bd1f01a9d1933d0c6801b0793
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69db5883ea3c3eaab4adede275212e53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e4c066b3d8185874e461e8305530fe4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-20 |
| filingDate |
2020-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8416266b26306a0f1f24ec6e3968fc05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72c864edc940913fce2fd5091793ccdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9022eaa9d64d4c96e43903eca9e2897b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_711cce460e3e609d54f0bab30e01efab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_144681a153e084699793953b59106224
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_068295c5180f087656beb414d813db46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d88d8e523594ae648ced3bb3bdeb740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9d485952d7e82c45947d84b7c9a8ccb |
| publicationDate |
2022-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022409594-A1 |
| titleOfInvention |
Cd4 mimic compound with anti-hiv activity |
| abstract |
CD4 mimic compounds having improved efficacy for anti-HIV treatment and more improved pharmacokinetics are provided. The compounds are represented by formula (I):wherein R1 is C2H4(OC2H4)n—OCH3 or CmH2m+1; R2 is O or NH; n is 3 to 25; and m is 4 to 22, or a salt thereof. HIV infection inhibitor compositions including the compound or a salt thereof as an active ingredient are also disclosed. |
| priorityDate |
2019-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |